Agios Pharmaceuticals Inc

Agios Pharmaceuticals, Inc. is a US-based global pharmaceutical corporation known for designing and implementing life-saving therapeutics for malignant diseases, primarily in the fields of oncology and rare genetic disorders. Operating in the pharmaceutical sector, Agios is involved with the discovery, development, and commercialisation of transformative medicines. Agios and its subsidiaries are recognised for its advanced treatments and focus on complex genetic disorders, such as its pyruvate kinase (PK) activator for deficient adults. Stay up to date on the share price of AGIO by adding it to your eToro watchlist.